NeoTYPE® Lymphoid Disorders Profile
Also known as: NeoTYPE Lymphoid, Lymphoid Disorders Profile
Use
The NeoTYPE Lymphoid Disorders Profile aids in the diagnosis and subclassification of lymphoid neoplasms and helps identify potential therapies based on the patient's unique molecular drivers. The profile includes analysis of genes known to be recurrently mutated in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), Richter's syndrome (RS), mantle cell lymphoma (MCL), marginal zone lymphoma (MZL), lymphoplasmacytic lymphoma (LPL), hairy cell leukemia (HCL), follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), Burkitt lymphoma (BL), double-hit lymphoma (DHL), and various T-cell neoplasms.
Special Instructions
Test reports include summary interpretation of all results to help guide treatment decisions.
Limitations
Highly acidic or prolonged decalcification processes will not yield sufficient nucleic acid to accurately perform molecular studies. Do not use zinc fixatives. Use positively charged slides and 10% NBF fixative if submitting slides.
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
14 days
Related Documents
For more information, please review the documents below
Specimen
Bone Marrow
Volume
2-3 mL
Minimum Volume
Not provided
Container
EDTA tube
Storage Instructions
Refrigerate specimen. Do not freeze. Use cold pack for transport, making sure cold pack is not in direct contact with specimen.
Causes for Rejection
Do not use: Mercury fixatives (B5); zinc fixatives.